跳至主要内容
临床试验/NCT04081480
NCT04081480终止不适用

Pharmacokinetics of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections in Children, Phase II (VALID II)

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2019年12月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
7
试验地点
1
主要终点
Cmax

研究概览

简要总结

Valacyclovir has replaced acyclovir in many clinical scenarios. Pharmacokinetic data support the use of oral valacyclovir in children, but practical problems exist in children having to take adult-dose tablets. A formulation with acceptable palatability, good pharmaceutical quality and possibility of flexible dosing is developed. Pharmacokinetic data of this formulation is missing.

The present study investigates the pharmacokinetics of valacyclovir oral solution in children by determine the area under the curve (AUC0-12), time above critical concentration (Ccrit), Cmax and Tmax of acyclovir.

Secondary, the safety profile of a single dose of valacyclovir oral solution will be determined.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
2 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subject is in the age of 2-12 years.
  • Subject has an indication for (val)acyclovir prophylaxis and are planned to receive valacyclovir oral solution.
  • Subject is managed with a central venous catheter (CVC/Port-a-Cath).
  • Subject's parents have signed the Informed Consent Form prior to screening evaluations.
  • Subject is willing to participate after study procedures are explained in comprehensible language for the child.

排除标准

  • Severe anemia (<6.0 mmol/L).
  • Full dose has not been taken.

研究组 & 干预措施

Valacyclovir oral solution

Other

Valacyclovir oral solution as administered in standard of care. Dosage: 10 mg/kg BID for children weighing less than 40 kg and 500 mg BID for children weighing 40 kg or more.

干预措施: Valacyclovir (Drug)

结局指标

主要结局

Cmax

时间窗: 12 hours

Maximum concentration of aciclovir

Area under the curve

时间窗: 12 hours

Acyclovir area under the curve (12h)

Tmax

时间窗: 12 hours

Time to reach maximum concentration of aciclovir

次要结局

  • Number of adverse events(1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验